FSTL1 protects against acute aortic dissection by suppressing vascular smooth muscle cell phenotypic switching and degradation of the extracellular matrix
- 3 December 2024
- journal article
- research article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 198, 60-73
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81870294, 81600351, 82170492)
This publication has 39 references indexed in Scilit:
- Activation of AMP-activated protein kinase ablated the formation of aortic dissection by suppressing vascular inflammation and phenotypic switching of vascular smooth muscle cellsInternational Immunopharmacology, 2022
- Thoracic perivascular adipose tissue inhibits VSMC apoptosis and aortic aneurysm formation in mice via the secretome of browning adipocytesActa Pharmacologica Sinica, 2022
- Follistatin-like 1 and its paralogs in heart development and cardiovascular diseaseHeart Failure Reviews, 2022
- Research Progress on the Pathogenesis of Aortic DissectionCurrent Problems in Cardiology, 2022
- Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune DiseasesMolecular Therapy, 2021
- Follistatin-like 1 in development and human diseasesCellular and Molecular Life Sciences, 2018
- Follistatin-like 1 protects against hypoxia-induced pulmonary hypertension in miceScientific Reports, 2017
- FSTL1 as a Potential Mediator of Exercise-Induced Cardioprotection in Post-Myocardial Infarction RatsScientific Reports, 2016
- Epicardial FSTL1 reconstitution regenerates the adult mammalian heartNature, 2015
- Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung developmentProceedings of the National Academy of Sciences, 2011